tm logo

Monitor this mark

View On USPTO

SMOFVAMIN
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 21 Nov 2024

Last Applicant/ Owned by

Fresenius Kabi AG

Else-Kroener-Str. 1

Bad Homburg

DE

61352

Serial Number

97746001 filed on 09th Jan 2023

Registration Number

N/A

Correspondent Address

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP

SUITE 400

WASHINGTON, DC 20007

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SMOFVAMIN

Pharmaceutical preparations, namely, infusion solutions for central intravenous nutritional therapy and infusion solutions for central intravenous parenteral nutrition

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, infusion solutions for central intravenous nutritional therapy and infusion solutions for central intravenous parenteral nutrition

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97746001

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 034618.035B

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Nov 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Nov 2024SOU EXTENSION 3 GRANTED
20th Nov 2024SOU TEAS EXTENSION RECEIVED
20th Nov 2024SOU EXTENSION 3 FILED
17th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th May 2024SOU EXTENSION 2 GRANTED
16th May 2024SOU TEAS EXTENSION RECEIVED
16th May 2024SOU EXTENSION 2 FILED
06th Dec 2023ITU LETTER MAILED, NO RESPONSE REQUIRED
06th Dec 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL